Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor

No-Receipt date 2008-02101 - 03/06/2008
No-Filing date 20080800025 - 03/06/2008
No-Granting date -
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 12/2008 - 20/01/2009
Gazette No-Publication date of granted patent -
Expiration date 16/09/2014
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status NOT VALID
Priorities US24473715/09/1988/US
US31910903/03/1989/US
Active Substance of Supplementary Certificates VECTIBIX-Panitumumab σε συνδυασμό με τουλάχιστον μία από ιρινοτεκάνη, 5-φθοροουρακίλη, cis-πλατίνα, πακλιταξέλη, γεμκτιταβίνη και καρβοπλατίνα.

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20020402077

Owners
CodeFirstnameSurnameAddressTownZIPCountry
147272 AVENTIS HOLDINGS INC. (ETAIREIA ORGANOMENI KATA TOUS NOMOUS TOU DELAWARE) 3711 KENNETT PIKE, SUITE 200, GREENVILLEDELAWARE19807 UNITED STATES OF AMERICA (USA)
232510 YEDA RESEARCH AND DEVELOPMENT CO., LTD. THE WEIZMANN INSTITUTE OF SCIENCE P.O. BOX 9576100 REHOVOT ISRAEL

Inventors
CodeFirstnameSurname
143825 BELLOT, FRANCOISE
143826 GIVOL, DAVID
143827 KRIS, RICHARD M.,
143828 SCHLESSINGER, JOSEPH

Representatives
CodeFirstnameSurnameAddressTownZip
403CHRISTINADIMOUKOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
4007ELENIPAPAKONSTANTINOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments

Payments history 1 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).